An intraocular lens technology

What makes LicriEye® Technology unique

People aged 65 years have a rather high chance of being affected by a cataract – clouding of the natural eye lens. Vision can only be restored by cataract surgery where the clouded lens is removed and replaced by an artificial lens. However, currently available lenses often fail to provide accurate vision for the patient. We have developed an artificial, re-adjustable technology which shall give patients the chance to restore their vision, and has the potential of their vision and has the potential to improve millions of lives.

Conventional Method
LicriEye® lens Method

A clear view

LicriEye would enable ophthalmologists to change the focus of the artificial lens after cataract surgery non-invasively using a laser, thus correcting potentially poor vision. Our liquid crystals expertise plays a key role here. Download here the specialized white paper to know more about cataract, its causes and the LicriEye solution.

Download the White Paper
Medical Advisory Board

Dr. Elizabeth Yeu is an Assistant Professor of Ophthalmology at Eastern Virginia Medical School and is a shareholder at Virginia Eye Consultants, in Norfolk, Va. She is the Medical Director of the Virginia Surgery Center and is a member of the Board of Directors for the Virginia Eye Foundation. She is a Cornea, Cataract and Refractive Surgery specialist, who completed her residency at Rush University Medical Center and her fellowship training from the Cullen Eye Institute of the Baylor College of Medicine.

Dr. Yeu provides guidance and governance across several national medical boards and committees. She is currently the Advisor to the Young Eye Surgeons (YES) Clinical Committee of the American Society of Cataract and Refractive Surgery (ASCRS), and is the Chair of the Cataract Section of Ophthalmic News & Education (ONE) Network for the American Ophthalmology (AAO).

Dr. Yeu has authored numerous articles and is a frequent lecturer nationally and internationally in the areas of refractive cataract surgery, anterior segment reconstruction, ocular surface disease management and surgical management of astigmatism. She is the editor-In-chief of U.S. Ophthalmic Review and served as the medical editor of the digital journal, Millennial Eye from 2015-2017.

Dr. Oliver Findl, is Professor of Ophthalmology and chairs the Department of Ophthalmology at the Hanusch Hospital, Vienna, Austria. He founded and heads the Vienna Institute for Research in Ocular Surgery (VIROS).

A research fellowship at Children’s Hospital in Boston was followed by residency and an anterior segment surgery fellowship at the Medical University of Vienna. He was a Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, London for several years.

His research interests are in the fields of posterior capsule opacification, optical biometry and the pathogenesis of myopia. He has authored over 250 articles in international peer-reviewed journals and is currently the secretary of the European Society of Cataract and Refractive Surgeons (ESCRS) as well as the treasurer of the Austrian Ophthalmological Society.

Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. He attended the Loyola-Stritch School of Medicine in Chicago and trained in Ophthalmology at the University of Minnesota and was granted the Elias Potter Lyon Chair in Ophthalmology. Dr. Holland also served as President of the Minnesota Academy of Ophthalmology.

Dr. Holland formerly served as the President for the American Society of Cataract and Refractive Surgery from 2011-2012. He was also a member of the Executive Committee and now serves as the Program Chair. He was former member of the Board of Trustees for the American Academy of Ophthalmology and was awarded their Life Achievement Honor Award.

Dr. Holland has a national and international reputation for his knowledge and expertise in the field of cornea and external disease. Dr. Holland is the author of over 270 articles in peer review journals and has edited Cornea, the most widely read textbook on corneal disease and surgery.

Contact Us!

Martin Schraub

Founder, LicriEye® lens technology

Joachim Reiss

Co-Founder, LicriEye® lens technology